NCT02021695View on ClinicalTrials.gov

DNA Methylation and Gene Expression in Qataris With Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

249

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions

Type 2 Diabetes

Trial Locations (1)

Unknown

Hamad Medical Corporation, Doha

Sponsors

Collaborators (1)

Hamad Medical Corporation

All Listed Sponsors

collaborator

Hamad Medical Corporation

INDUSTRY

collaborator

Weill Cornell Medical College in Qatar

OTHER

lead

Weill Medical College of Cornell University

OTHER